Assay.Works offers three unique libraries of small interfering RNA (siRNA) targeting the extended human druggable genome, assembled from diverse RNA sources. These libraries include built-in redundancy to identify false hits statistically. They're valuable for target identification, validation, pathway deconvolution, and patient stratification. Additionally, they support genetic and pharmacological interaction screening, swiftly identifying disease-relevant targets and pathways.
Applications
- Target identification and validation, pathway deconvolution, patient stratification.
- Genetic and pharmacological interaction screening. Query-RNA or compound-based interaction screens represent a powerful technology to rapidly identify targets and pathways involved in disease-relevant phenotypes.
| Library | Covered Genes | RNA Count | RNA/Gene |
|---|---|---|---|
| RNAi.budget | 9,989 | 40,066 | 4.0 |
| RNAi.value | 10,453 | 56,901 | 5.4 |
| RNAi.premium | 10,458 | 96,967 | 9.3 |
